title: Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping.
abstract: We investigated whether V3-binding assays might be useful to analyze human immunodeficiency virus type 1 (HIV-1) variants in different geographic regions. We showed that strong cross-reactivity between subtype-specific V3 peptides is almost inevitable in standard indirect enzyme-linked immunosorbent assays (EIA), impairing precise serological subtyping. We therefore developed a subtype-specific EIA (HIV-1 SSEIA) that uses the principle of blocking by an excess of peptide in the liquid phase. Using 231 serum samples collected from HIV-1-infected individuals in 10 different geographical areas from 4 continents, we showed that this approach detected the dominant subtype reactivity in more than 97% of the cases. Internal controls (0 and 100% blocking) were used for every sample such that comparative analysis was possible, independent of both the individual humoral response and the time of collection during the course of infection. This was validated by the excellent concordance of the serological profiles of couples and the temporal stability of the serological profile in individuals. The geographical distribution of the various subtypes in the SSEIA was in agreement with the present knowledge of the distribution of the various genotypes. Although the goal of this study was not an extensive seroepidemiological survey, our results showed that the various profiles in most of the regions were relatively homogeneous, but in central Africa there was a large diversity of serological profiles. Cluster analysis identified a limited number of V3 serogroups of serotypes within the HIV-1 group M. Five serogroups, some of them divided into subgroups, were identified and characterized by a mean serological profile. Our data confirmed that subtypes A and C, although being dissimilar genetic subtypes, present conserved antigenic properties in the V3 region, and that the D subtype is probably the most divergent within the group M (B Korber et al., J Virol 1994;68:6730). Cluster analysis showed a clear correlation between position within the dendrogram and geographical origin of the samples. This is further support for the reliability and thereof the usefulness of the SSEIA. This simple methodology may help facilitate the analysis of the distribution of various HIV-1 subtypes circulating in different populations and regions.
authors.affiliation: Laboratoire de Virologie, URA CNRS 1334, Université François Rabelais, Tours, France.
authors.forename: F
authors.initials: F
authors.lastname: Barin
authors.forename: Y
authors.initials: Y
authors.lastname: Lahbabi
authors.forename: L
authors.initials: L
authors.lastname: Buzelay
authors.forename: B
authors.initials: B
authors.lastname: Lejeune
authors.forename: A
authors.initials: A
authors.lastname: Baillou-Beaufils
authors.forename: F
authors.initials: F
authors.lastname: Denis
authors.forename: C
authors.initials: C
authors.lastname: Mathiot
authors.forename: S
authors.initials: S
authors.lastname: M'Boup
authors.forename: V
authors.initials: V
authors.lastname: Vithayasai
authors.forename: U
authors.initials: U
authors.lastname: Dietrich
authors.forename: A
authors.initials: A
authors.lastname: Goudeau
mesh_terms: D000595:Amino Acid Sequence; D000916:Antibody Diversity / Q000276:immunology*; D001666:Binding Sites, Antibody; D016000:Cluster Analysis; D016384:Consensus Sequence; D005838:Genotype; D015483:HIV Antibodies / Q000276:immunology*; D015699:HIV Envelope Protein gp120 / Q000737:chemistry / Q000276:immunology*; D015658:HIV Infections / Q000097:blood / Q000276:immunology*; D015497:HIV-1 / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007124:Immunoenzyme Techniques; D008137:Longitudinal Studies; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000737:chemistry / Q000276:immunology*
chemical_list: D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; C059762:HIV envelope protein gp120 (305-321); D010446:Peptide Fragments